225 related articles for article (PubMed ID: 19336566)
1. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
Camp NJ; Farnham JM; Wong J; Christensen GB; Thomas A; Cannon-Albright LA
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1290-4. PubMed ID: 19336566
[TBL] [Abstract][Full Text] [Related]
2. Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.
Lu L; Sun J; Isaacs SD; Wiley KE; Smith S; Pruett K; Zhu Y; Zhang Z; Wiklund F; Grönberg H; Walsh PC; Chang BL; Zheng SL; Isaacs WB; Xu J
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2132-6. PubMed ID: 19549809
[TBL] [Abstract][Full Text] [Related]
3. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
Lou H; Yeager M; Li H; Bosquet JG; Hayes RB; Orr N; Yu K; Hutchinson A; Jacobs KB; Kraft P; Wacholder S; Chatterjee N; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Ma J; Gaziano JM; Stampfer M; Schumacher FR; Giovannucci E; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Anderson SK; Tucker M; Hoover RN; Fraumeni JF; Thomas G; Hunter DJ; Dean M; Chanock SJ
Proc Natl Acad Sci U S A; 2009 May; 106(19):7933-8. PubMed ID: 19383797
[TBL] [Abstract][Full Text] [Related]
4. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.
Chang BL; Cramer SD; Wiklund F; Isaacs SD; Stevens VL; Sun J; Smith S; Pruett K; Romero LM; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Adolfsson J; Liu W; Kim JW; Duggan D; Carpten J; Zheng SL; Rodriguez C; Isaacs WB; Grönberg H; Xu J
Hum Mol Genet; 2009 Apr; 18(7):1368-75. PubMed ID: 19153072
[TBL] [Abstract][Full Text] [Related]
5. Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.
Teerlink CC; Thibodeau SN; McDonnell SK; Schaid DJ; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Fitzgerald LM; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Wahlfors T; Tammela T; Schleutker J; Wiklund F; Grönberg H; Emanuelsson M; Carpten J; Bailey-Wilson J; Whittemore AS; Oakley-Girvan I; Hsieh CL; Catalona WJ; Zheng SL; Jin G; Lu L; Xu J; ; Camp NJ; Cannon-Albright LA
Hum Genet; 2014 Mar; 133(3):347-56. PubMed ID: 24162621
[TBL] [Abstract][Full Text] [Related]
6. Early onset prostate cancer has a significant genetic component.
Lange EM; Salinas CA; Zuhlke KA; Ray AM; Wang Y; Lu Y; Ho LA; Luo J; Cooney KA
Prostate; 2012 Feb; 72(2):147-56. PubMed ID: 21538423
[TBL] [Abstract][Full Text] [Related]
7. The prostate cancer risk locus at 10q11 is associated with DNA repair capacity.
Rinckleb AE; Surowy HM; Luedeke M; Varga D; Schrader M; Hoegel J; Vogel W; Maier C
DNA Repair (Amst); 2012 Aug; 11(8):693-701. PubMed ID: 22677538
[TBL] [Abstract][Full Text] [Related]
8. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.
Breyer JP; McReynolds KM; Yaspan BL; Bradley KM; Dupont WD; Smith JR
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2137-44. PubMed ID: 19567509
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
Kim S; Shin C; Jee SH
Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
[TBL] [Abstract][Full Text] [Related]
11. Generalizability of associations from prostate cancer genome-wide association studies in multiple populations.
Waters KM; Le Marchand L; Kolonel LN; Monroe KR; Stram DO; Henderson BE; Haiman CA
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1285-9. PubMed ID: 19318432
[TBL] [Abstract][Full Text] [Related]
12. Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese.
Akamatsu S; Takata R; Haiman CA; Takahashi A; Inoue T; Kubo M; Furihata M; Kamatani N; Inazawa J; Chen GK; Le Marchand L; Kolonel LN; Katoh T; Yamano Y; Yamakado M; Takahashi H; Yamada H; Egawa S; Fujioka T; Henderson BE; Habuchi T; Ogawa O; Nakamura Y; Nakagawa H
Nat Genet; 2012 Feb; 44(4):426-9, S1. PubMed ID: 22366784
[TBL] [Abstract][Full Text] [Related]
13. A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q.
Teerlink C; Farnham J; Allen-Brady K; Camp NJ; Thomas A; Leachman S; Cannon-Albright L
Hum Genet; 2012 Jan; 131(1):77-85. PubMed ID: 21706340
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
Teerlink CC; Leongamornlert D; Dadaev T; Thomas A; Farnham J; Stephenson RA; Riska S; McDonnell SK; Schaid DJ; Catalona WJ; Zheng SL; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Giles GG; Southey MC; Fitzgerald LM; Rinckleb A; Luedeke M; Maier C; Stanford JL; Ostrander EA; Kaikkonen EM; Sipeky C; Tammela T; Schleutker J; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cancel-Tassin G; Cussenot O; Mandal D; Laurie C; Laurie C; ; ; Thibodeau SN; Eeles RA; Kote-Jarai Z; Cannon-Albright L
Hum Genet; 2016 Aug; 135(8):923-38. PubMed ID: 27262462
[TBL] [Abstract][Full Text] [Related]
16. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jin G; Lu L; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Cannon-Albright LA; Camp NJ; Teerlink CC; Fitzgerald LM; Stanford JL; Wiley KE; Isaacs SD; Walsh PC; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Thibodeau SN; McDonnell SK; Schaid DJ; Wiklund F; Grönberg H; Emanuelsson M; Whittemore AS; Oakley-Girvan I; Hsieh CL; Wahlfors T; Tammela T; Schleutker J; Catalona WJ; Zheng SL; Ostrander EA; Isaacs WB; Xu J;
Hum Genet; 2012 Jul; 131(7):1095-103. PubMed ID: 22198737
[TBL] [Abstract][Full Text] [Related]
17. Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees.
Farnham JM; Camp NJ; Swensen J; Tavtigian SV; Albright LA
Hum Genet; 2005 Feb; 116(3):179-85. PubMed ID: 15592687
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees.
Christensen GB; Camp NJ; Farnham JM; Cannon-Albright LA
Prostate; 2007 May; 67(6):605-13. PubMed ID: 17299800
[TBL] [Abstract][Full Text] [Related]
19. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
[TBL] [Abstract][Full Text] [Related]
20. Validation of genome-wide prostate cancer associations in men of African descent.
Chang BL; Spangler E; Gallagher S; Haiman CA; Henderson B; Isaacs W; Benford ML; Kidd LR; Cooney K; Strom S; Ingles SA; Stern MC; Corral R; Joshi AD; Xu J; Giri VN; Rybicki B; Neslund-Dudas C; Kibel AS; Thompson IM; Leach RJ; Ostrander EA; Stanford JL; Witte J; Casey G; Eeles R; Hsing AW; Chanock S; Hu JJ; John EM; Park J; Stefflova K; Zeigler-Johnson C; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):23-32. PubMed ID: 21071540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
